Universidade de São Paulo. São Paulo, São Paulo, Brazil.
Rev Bras Enferm. 2022 Mar 7;75Suppl 1(Suppl 1):e20201374. doi: 10.1590/0034-7167-2020-1374. eCollection 2022.
to identify and synthesize studies on the effects of cannabis use and its relation with SARS-CoV-2, as well as the therapeutic possibilities of using cannabinoids in the prevention and treatment of COVID-19.
scoping review, in the BVS, PubMed, SCIELO, CINAHL, SCOPUS, Web of Science, MedNar, CAPES and ProQuest databases, with no language restriction and year limitation. Narrative synthesis was performed.
cannabis use causes changes in the respiratory and vascular system, it reduces the production of cytokines, which affects the users' immune system, increasing the susceptibility to infection and progression of COVID-19. However, studies have suggested the use of cannabinoids in the prophylaxis and treatment of COVID-19, due to their anti-inflammatory effect.
the use of inhaled cannabis increases the progression and severity of the infection. On the other hand, the benefits of cannabinoids seem promising to modulate the immune system, but it needs further studies.
识别和综合研究大麻使用及其与 SARS-CoV-2 的关系,以及使用大麻素预防和治疗 COVID-19 的治疗可能性。
在 BVS、PubMed、SCIELO、CINAHL、SCOPUS、Web of Science、MedNar、CAPES 和 ProQuest 数据库中进行范围综述,不限制语言和年份。进行叙述性综合。
大麻使用会引起呼吸系统和血管系统的变化,它会减少细胞因子的产生,从而影响使用者的免疫系统,增加感染和 COVID-19 进展的易感性。然而,由于其抗炎作用,已有研究表明大麻素可用于 COVID-19 的预防和治疗。
吸入大麻会增加感染的进展和严重程度。另一方面,大麻素的益处似乎很有希望调节免疫系统,但还需要进一步研究。